Business Context and Reporting Period
Optimumbank Holdings, Inc. filed a Form 8-K Current Report on August 14, 2012, covering events occurring on August 15, 2012, and July 9, 2012. The filing details unregistered sales of equity securities under Item 3.02.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on capital raising activities:
- August 15, 2012 Transaction: Sale of 3,000,000 newly issued common shares at $0.40 per share to an individual accredited investor.
- July 9, 2012 Transaction: Sale of 500,000 newly issued common shares at $0.40 per share to Joel Klein, a newly appointed director.
- Total Proceeds Disclosed: $1,400,000 from the two specific transactions mentioned ($1,200,000 + $200,000).
- Dilution Impact: The August 15 transaction represented 9.9% of the outstanding shares immediately after the transaction.
Material Changes
The primary material change is the increase in outstanding common stock and the infusion of capital through private placements. The August 15 transaction significantly altered the capital structure, with the new shares constituting nearly 10% of the post-transaction equity. Additionally, the July 9 transaction finalized a subscription agreement with a new director contingent on regulatory approval.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the shares were sold unregistered under Section 4(2) of the Securities Act of 1933. The transactions were executed as private offerings not involving a public offering.
Investor Verification Checklist
- Verify the total number of outstanding shares post-August 15 to confirm the 9.9% dilution calculation.
- Confirm the regulatory approval status for Joel Klein's directorship and the timing of his funding.
- Review the full "Private Offering" details from the May 11, 2012 Form 8-K to understand the total scope of the 37,500,000 share offering.
- Assess the company's use of the $1.4 million in proceeds from these specific transactions.